286:
33:
691:
Cosimano, Emily; Jennings, Cheryl; Moyo, Sikhulile; Dadson, Oswald; Luetkemeyer, Annie; Dwyer, Jay; Hughes, Valery; Grenade, Joanne; Stroberg, Todd; Ilmet, Tiina; Henn, Sarah; Kiger, Kristi; Flynn, Teri; Sbrolla, Amy; Nuffer, Kathleen; Wyles, David; McGregor, Donna; Hawkins, Claudia; Williams, Brett; Green, Tondria; Tebas, Pablo; Kim, Deborah; Bedimo, Roger; Wise, Holly; Arduino, Roberto C; Villamil, Aristoteles (August 1, 2019).
667:
612:
549:
494:
432:
353:
622:
Naggie, Susanna; Cooper, Curtis; Saag, Michael; Workowski, Kimberly; Ruane, Peter; Towner, William J.; Marks, Kristen; Luetkemeyer, Anne; Baden, Rachel P.; Sax, Paul E.; Gane, Edward; Santana-Bagur, Jorge; Stamm, Luisa M.; Yang, Jenny C.; German, Polina; Dvory-Sobol, Hadas; Ni, Liyun; Pang, Phillip
690:
Naggie, Susanna; Fierer, Daniel S; Hughes, Michael D; Kim, Arthur Y; Luetkemeyer, Annie; Vu, Vincent; Roa, Jhoanna; Rwema, Steve; Brainard, Diana M; McHutchison, John G; Peters, Marion G; Kiser, Jennifer J; Marks, Kristen M; Chung, Raymond T; Alston-Smith, Beverly; Weichmann, Laura; Sise, Thucuma;
504:
Havlir, Diane V.; Kendall, Michelle A.; Ive, Prudence; Kumwenda, Johnstone; Swindells, Susan; Qasba, Sarojini S.; Luetkemeyer, Anne F.; Hogg, Evelyn; Rooney, James F.; Wu, Xingye; Hosseinipour, Mina C.; Lalloo, Umesh; Veloso, Valdilea G.; Some, Fatuma F.; Kumarasamy, N.; Padayatchi, Nesri; Santos,
1093:
Beigel, John H.; Tomashek, Kay M.; Dodd, Lori E.; Mehta, Aneesh K.; Zingman, Barry S.; Kalil, Andre C.; Hohmann, Elizabeth; Chu, Helen Y.; Luetkemeyer, Annie; Kline, Susan; Lopez de
Castilla, Diego; Finberg, Robert W.; Dierberg, Kerry; Tapson, Victor; Hsieh, Lanny; Patterson, Thomas F.; Paredes,
278:) that is produced at elevated levels in patients who take rifampicin, and breaks down the efavirenz. To overcome this, the 2012 FDA recommendations proposed larger doses of efavirenz. Luetkemeyer argued that the recommendations were not appropriate for all populations in the
1094:
Roger; Sweeney, Daniel A.; Short, William R.; Touloumi, Giota; Lye, David Chien; Ohmagari, Norio; Oh, Myoung-don; Ruiz-Palacios, Guillermo M.; Benfield, Thomas; Fätkenheuer, Gerd; Kortepeter, Mark G.; Atmar, Robert L.; Creech, C. Buddy; Lundgren, Jens; Babiker, Abdel G.;
693:"Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals"
562:"Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection"
505:
Breno R.; Reid, Stewart; Hakim, James; Mohapi, Lerato; Mugyenyi, Peter; Sanchez, Jorge; Lama, Javier R.; Pape, Jean W.; Sanchez, Alejandro; Asmelash, Aida; Moko, Evans; Sawe, Fred; Andersen, Janet; Sanne, Ian (October 20, 2011).
559:
Sandler, Netanya G.; Zhang, Xinyan; Bosch, Ronald J.; Funderburg, Nicholas T.; Choi, Andrew I.; Robinson, Janet K.; Fine, Derek M.; Coombs, Robert W.; Jacobson, Jeffrey M.; Landay, Alan L.; Douek, Daniel C. (November 15, 2014).
301:
task force. In line with most official advice, Luetkemeyer called for older people and those with preexisting conditions to be more careful during the outbreak, as the virus "taxes all organ systems". She studied which
623:
S.; McHutchison, John G.; Stedman, Catherine A.M.; Morales-Ramirez, Javier O.; Bräu, Norbert; Jayaweera, Dushyantha; Colson, Amy E.; Tebas, Pablo; Wong, David K.; Dieterich, Douglas; Sulkowski, Mark (August 20, 2015).
736:
Grant, Juliana S; Stafylis, Chrysovalantis; Celum, Connie; Grennan, Troy; Haire, Bridget; Kaldor, John; Luetkemeyer, Anne F; Saunders, John M; Molina, Jean-Michel; Klausner, Jeffrey D (September 1, 2019).
1098:, Sarah; Neaton, James D.; Burgess, Timothy H.; Bonnett, Tyler; Green, Michelle; Makowski, Mat; Osinusi, Anu; Nayak, Seema; Lane, H. Clifford; ACTT-1 Study Group, Members (November 5, 2020).
782:
Garcia-Cremades, Maria; Solans, Belen P.; Hughes, Emma; Ernest, Jacqueline P.; Wallender, Erika; Aweeka, Francesca; Luetkemeyer, Annie; Savic, Radojka M (April 14, 2020).
282:, and could result in more drug toxicity. She showed that increasing the dosage of efavirenz may cause more side effects—as well as coming at a greater financial cost.
1259:
1067:
1254:
979:
442:
Luetkemeyer, Annie F.; Charlebois, Edwin D.; Flores, Laura L.; Bangsberg, David R.; Deeks, Steven G.; Martin, Jeffrey N.; Havlir, Diane V. (January 11, 2007).
960:
380:
Luetkemeyer, Annie; Hare, C. Bradley; Stansell, John; Tien, Phyllis C.; Charlesbois, Edwin; Lum, Paula; Havlir, Diane; Peters, Marion (January 1, 2006).
1161:
1187:
1289:
1147:
998:
306:
patients were most likely to benefit from treatment, when during the illness was the best time for treatment, and which types of treatment (
1279:
784:"Optimizing hydroxychloroquine dosing for patients with COVID-19: An integrative modeling approach for effective drug repurposing"
341:
guidelines recommend treatment only if patients are hospitalized or have strong risk factors for progression into severe disease.
1220:
227:
138:
1249:
231:
142:
1023:
1294:
861:
1264:
1274:
1284:
297:, Luetkemeyer led investigations into potential therapies for the disease. She is a member of the UCSF cross-campus
1049:
368:
335:
318:
healthcare workers and household contacts can do to prevent disease spread. Luetkemeyer has called for more
251:
150:
319:
842:
678:
196:
444:"Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected Individuals"
242:
In 2012 Luetkemeyer called for investigations into the doses of medications used for the treatment of
1229:
188:
1244:
223:
83:
1141:
1024:"About the Cross-campus Infectious Disease COVID-19 Task Force | HIV, ID and Global Medicine"
879:
1269:
961:"UCSF/SFGH Researchers Call for Change in New FDA Recommendation on HIV and TB Drug Doses"
382:"Clinical Presentation and Course of Acute Hepatitis C Infection in HIV-Infected Patients"
8:
215:
79:
901:
358:
1124:
1099:
810:
783:
765:
738:
719:
692:
651:
624:
596:
561:
533:
506:
478:
443:
416:
398:
381:
323:
219:
1162:"UCSF's noon grand rounds: A slow reopening, racial disparities and no quick remedies"
1225:
1129:
815:
770:
724:
656:
601:
583:
538:
483:
465:
421:
403:
311:
294:
158:
1119:
1111:
805:
795:
760:
750:
714:
704:
646:
636:
591:
573:
528:
518:
473:
455:
411:
393:
211:
207:
1188:"Anti-viral Remdesivir, Wall Street's darling, may not even work against COVID-19"
230:. In 2006, she completed advance training in clinical research there, and then an
275:
154:
285:
32:
999:"Trials of drugs to prevent coronavirus infection begin in health care workers"
460:
307:
200:
1216:
929:
1238:
587:
469:
407:
279:
578:
165:. She has also researched treatment of COVID-19 as a co-infection with HIV.
1133:
819:
774:
728:
660:
605:
542:
487:
425:
314:) were most appropriate. She has also outlined what pre- and post-exposure
263:
254:
had rewritten the recommendations in 2012. In a series of small studies in
247:
146:
1115:
670:
641:
615:
552:
523:
497:
435:
755:
709:
315:
192:
109:
1095:
739:"Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections"
507:"Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis"
338:
331:
327:
259:
162:
800:
625:"Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1"
267:
174:
130:
122:
63:
441:
226:. In 2002 and 2003, Luetkemeyer trained in internal medicine at the
303:
298:
178:
134:
126:
67:
853:
781:
872:
255:
191:. She is the youngest of three sisters, one of whom is actress
1068:"What scientists do and don't know about treating coronavirus"
183:
137:
who is
Professor of Medicine and Infectious Diseases at the
558:
379:
448:
American
Journal of Respiratory and Critical Care Medicine
1100:"Remdesivir for the Treatment of Covid-19 — Final Report"
735:
621:
271:
243:
503:
1092:
980:"Treatment options for COVID-19: Dr. Annie Luetkemeyer"
187:
Frey) and John
Alexander Luetkemeyer Jr., a commercial
978:
Wachter, Robert; Luetkemeyer, Annie (March 15, 2020).
1041:
971:
689:
18:
American physician and infectious diseases researcher
199:, Maryland. In 1984, Luetkemeyer graduated from the
1050:"How to Protect Older People From the Coronavirus"
977:
954:
952:
950:
344:
1236:
1260:University of California, San Francisco faculty
947:
386:Journal of Acquired Immune Deficiency Syndromes
1255:University of California, San Francisco alumni
996:
834:
274:. The drugs interact through a liver enzyme (
1146:: CS1 maint: numeric names: authors list (
840:
676:
173:Luetkemeyer was born on April 13, 1972, in
168:
31:
1123:
809:
799:
764:
754:
718:
708:
650:
640:
595:
577:
532:
522:
477:
459:
415:
397:
859:
788:Clinical Pharmacology & Therapeutics
284:
1221:University of California, San Francisco
965:University of California, San Francisco
326:. She led a clinical trial of the drug
228:University of California, San Francisco
139:University of California, San Francisco
1290:21st-century American women physicians
1237:
1047:
890:(1). Calvert School: 16–19. Fall 2012.
958:
860:Marbella, Jean (September 12, 2010).
841:Luetkemeyer, Annie (August 2, 2016).
677:Luetkemeyer, Annie (August 2, 2016).
666:
611:
548:
493:
431:
997:Kupferschmidt, Kai (April 7, 2020).
924:
922:
161:Luetkemeyer led a clinical trial of
930:"Annie Luetkemeyer | UCSF Profiles"
880:"The Illustrious Luetkemeyer Girls"
266:, could limit the effectiveness of
13:
399:10.1097/01.qai.0000191281.77954.27
14:
1306:
1210:
919:
206:In 1994, Luetkemeyer received an
1280:21st-century American physicians
1048:Hafner, Katie (March 14, 2020).
665:
610:
547:
492:
430:
351:
1180:
1154:
1104:New England Journal of Medicine
1086:
1060:
629:New England Journal of Medicine
511:New England Journal of Medicine
345:Selected works and publications
1016:
990:
959:Bardi, Jason (July 23, 2012).
894:
566:Journal of Infectious Diseases
336:San Francisco General Hospital
93:Infectious diseases researcher
1:
1250:Harvard Medical School alumni
827:
1295:American medical researchers
743:Clinical Infectious Diseases
697:Clinical Infectious Diseases
330:with other researchers like
320:randomized controlled trials
289:Dr Annie Luetkemeyer in 2021
252:Food and Drug Administration
151:human immunodeficiency virus
7:
862:"Julie Bowen's modern life"
218:. In 1999, she received an
10:
1311:
1265:Stanford University alumni
461:10.1164/rccm.200608-1088OC
181:, to Suzanne Luetkemeyer (
1275:Women medical researchers
902:"Anne F. Luetkemeyer, MD"
237:
105:
97:
89:
75:
42:
30:
23:
1285:Physicians from Maryland
843:"Hepatitis C is Curable"
679:"Hepatitis C is Curable"
322:to assess the impact of
169:Early life and education
1230:UCSF School of Medicine
270:, a drug used to treat
262:, a drug used to treat
258:it had been shown that
129:, U.S.) is an American
290:
224:Harvard Medical School
121:(born April 13, 1972,
84:Harvard Medical School
1116:10.1056/NEJMoa2007764
642:10.1056/NEJMoa1501315
579:10.1093/infdis/jiu305
524:10.1056/NEJMoa1013607
288:
189:real estate developer
141:. She specializes in
234:fellowship in 2007.
210:with distinction in
119:Annie F. Luetkemeyer
47:Annie F. Luetkemeyer
1072:National Geographic
312:anti-inflammatories
216:Stanford University
143:infectious diseases
80:Stanford University
37:Luetkemeyer in 2021
1054:The New York Times
756:10.1093/cid/ciz866
710:10.1093/cid/ciy913
324:hydroxychloroquine
291:
232:infectious disease
220:Doctor of Medicine
1226:Annie Luetkemeyer
1217:Annie Luetkemeyer
1110:(19): 1813–1826.
934:profiles.ucsf.edu
866:The Baltimore Sun
572:(10): 1549–1554.
517:(16): 1482–1491.
369:Annie Luetkemeyer
295:COVID-19 pandemic
195:. She grew up in
159:COVID-19 pandemic
116:
115:
98:Years active
25:Annie Luetkemeyer
1302:
1204:
1203:
1201:
1199:
1194:. April 18, 2020
1184:
1178:
1177:
1175:
1173:
1168:. April 17, 2020
1158:
1152:
1151:
1145:
1137:
1127:
1090:
1084:
1083:
1081:
1079:
1074:. March 25, 2020
1064:
1058:
1057:
1045:
1039:
1038:
1036:
1034:
1028:hividgm.ucsf.edu
1020:
1014:
1013:
1011:
1009:
994:
988:
987:
975:
969:
968:
956:
945:
944:
942:
940:
926:
917:
916:
914:
912:
898:
892:
891:
884:Reflections 2012
876:
870:
869:
857:
851:
850:
838:
823:
813:
803:
801:10.1002/cpt.1856
778:
768:
758:
749:(6): 1247–1253.
732:
722:
712:
686:
669:
668:
664:
654:
644:
614:
613:
609:
599:
581:
551:
550:
546:
536:
526:
496:
495:
491:
481:
463:
434:
433:
429:
419:
401:
355:
354:
212:American Studies
197:Ruxton-Riderwood
145:, in particular
60:
56:
54:
35:
21:
20:
1310:
1309:
1305:
1304:
1303:
1301:
1300:
1299:
1235:
1234:
1213:
1208:
1207:
1197:
1195:
1186:
1185:
1181:
1171:
1169:
1160:
1159:
1155:
1139:
1138:
1091:
1087:
1077:
1075:
1066:
1065:
1061:
1046:
1042:
1032:
1030:
1022:
1021:
1017:
1007:
1005:
995:
991:
984:The Hospitalist
976:
972:
957:
948:
938:
936:
928:
927:
920:
910:
908:
900:
899:
895:
878:
877:
873:
858:
854:
839:
835:
830:
376:
375:
374:
356:
352:
347:
276:cytochrome P450
240:
171:
155:viral hepatitis
82:
71:
61:
58:
52:
50:
49:
48:
38:
26:
19:
12:
11:
5:
1308:
1298:
1297:
1292:
1287:
1282:
1277:
1272:
1267:
1262:
1257:
1252:
1247:
1233:
1232:
1223:
1212:
1211:External links
1209:
1206:
1205:
1179:
1153:
1085:
1059:
1040:
1015:
1003:Science | AAAS
989:
970:
946:
918:
893:
871:
852:
832:
831:
829:
826:
825:
824:
794:(2): 253–263.
779:
733:
703:(3): 514–522.
687:
674:
635:(8): 705–713.
619:
556:
501:
454:(7): 737–742.
439:
357:
350:
349:
348:
346:
343:
246:infection and
239:
236:
201:Calvert School
170:
167:
114:
113:
107:
103:
102:
99:
95:
94:
91:
87:
86:
77:
73:
72:
62:
57:April 13, 1972
46:
44:
40:
39:
36:
28:
27:
24:
17:
9:
6:
4:
3:
2:
1307:
1296:
1293:
1291:
1288:
1286:
1283:
1281:
1278:
1276:
1273:
1271:
1268:
1266:
1263:
1261:
1258:
1256:
1253:
1251:
1248:
1246:
1245:Living people
1243:
1242:
1240:
1231:
1227:
1224:
1222:
1218:
1215:
1214:
1193:
1192:Mission Local
1189:
1183:
1167:
1166:Mission Local
1163:
1157:
1149:
1143:
1135:
1131:
1126:
1121:
1117:
1113:
1109:
1105:
1101:
1097:
1089:
1073:
1069:
1063:
1055:
1051:
1044:
1029:
1025:
1019:
1004:
1000:
993:
985:
981:
974:
966:
962:
955:
953:
951:
935:
931:
925:
923:
907:
903:
897:
889:
885:
881:
875:
867:
863:
856:
848:
844:
837:
833:
821:
817:
812:
807:
802:
797:
793:
789:
785:
780:
776:
772:
767:
762:
757:
752:
748:
744:
740:
734:
730:
726:
721:
716:
711:
706:
702:
698:
694:
688:
684:
680:
675:
672:
662:
658:
653:
648:
643:
638:
634:
630:
626:
620:
617:
607:
603:
598:
593:
589:
585:
580:
575:
571:
567:
563:
557:
554:
544:
540:
535:
530:
525:
520:
516:
512:
508:
502:
499:
489:
485:
480:
475:
471:
467:
462:
457:
453:
449:
445:
440:
437:
427:
423:
418:
413:
409:
405:
400:
395:
391:
387:
383:
378:
377:
372:
371:
370:
364:
360:
342:
340:
337:
333:
329:
325:
321:
317:
313:
309:
305:
300:
296:
287:
283:
281:
280:United States
277:
273:
269:
265:
261:
257:
253:
249:
245:
235:
233:
229:
225:
221:
217:
213:
209:
204:
202:
198:
194:
190:
186:
185:
180:
176:
166:
164:
160:
157:. During the
156:
152:
148:
144:
140:
136:
132:
128:
124:
120:
111:
108:
104:
100:
96:
92:
88:
85:
81:
78:
74:
69:
65:
59:(age 52)
45:
41:
34:
29:
22:
16:
1196:. Retrieved
1191:
1182:
1170:. Retrieved
1165:
1156:
1142:cite journal
1107:
1103:
1088:
1076:. Retrieved
1071:
1062:
1053:
1043:
1031:. Retrieved
1027:
1018:
1006:. Retrieved
1002:
992:
983:
973:
964:
937:. Retrieved
933:
909:. Retrieved
905:
896:
887:
883:
874:
865:
855:
846:
836:
791:
787:
746:
742:
700:
696:
682:
632:
628:
569:
565:
514:
510:
451:
447:
392:(1): 31–36.
389:
385:
367:
366:
365:profile for
362:
292:
264:tuberculosis
248:tuberculosis
241:
205:
182:
172:
147:tuberculosis
118:
117:
101:1999–present
15:
1270:1972 births
316:prophylaxis
293:During the
193:Julie Bowen
110:Julie Bowen
1239:Categories
828:References
339:SARS-CoV-2
332:Sarah Pett
328:remdesivir
308:antivirals
260:rifampicin
163:remdesivir
135:researcher
90:Occupation
53:1972-04-13
1198:April 19,
1172:April 19,
1078:April 15,
1033:April 20,
1008:April 15,
939:April 15,
911:April 15,
588:0022-1899
470:1073-449X
408:1525-4135
268:efavirenz
175:Baltimore
131:physician
123:Baltimore
106:Relatives
76:Education
64:Baltimore
1134:32445440
820:32285930
775:31504345
729:31220220
671:Wikidata
661:26196665
616:Wikidata
606:24864123
553:Wikidata
543:22010914
498:Wikidata
488:17218620
436:Wikidata
426:16340470
304:COVID-19
299:COVID-19
179:Maryland
127:Maryland
112:(sister)
68:Maryland
1125:7262788
906:IAS-USA
811:7262072
766:7319058
720:6637278
652:4892372
597:4215074
534:3327101
479:1899289
417:4050666
361:has an
359:Scholia
1132:
1122:
818:
808:
773:
763:
727:
717:
659:
649:
604:
594:
586:
541:
531:
486:
476:
468:
424:
414:
406:
363:author
334:. The
256:Europe
250:. The
238:Career
222:from
214:from
1200:2020
1174:2020
1148:link
1130:PMID
1096:Pett
1080:2020
1035:2020
1010:2020
941:2020
913:2020
847:KQED
816:PMID
771:PMID
725:PMID
683:KQED
657:PMID
602:PMID
584:ISSN
539:PMID
484:PMID
466:ISSN
422:PMID
404:ISSN
153:and
133:and
70:U.S.
43:Born
1228:at
1219:at
1120:PMC
1112:doi
1108:383
888:XIX
806:PMC
796:doi
792:108
761:PMC
751:doi
715:PMC
705:doi
647:PMC
637:doi
633:373
592:PMC
574:doi
570:210
529:PMC
519:doi
515:365
474:PMC
456:doi
452:175
412:PMC
394:doi
310:or
272:HIV
244:HIV
184:née
1241::
1190:.
1164:.
1144:}}
1140:{{
1128:.
1118:.
1106:.
1102:.
1070:.
1052:.
1026:.
1001:.
982:.
963:.
949:^
932:.
921:^
904:.
886:.
882:.
864:.
845:.
814:.
804:.
790:.
786:.
769:.
759:.
747:70
745:.
741:.
723:.
713:.
701:69
699:.
695:.
681:.
673:()
655:.
645:.
631:.
627:.
618:()
600:.
590:.
582:.
568:.
564:.
555:()
537:.
527:.
513:.
509:.
500:()
482:.
472:.
464:.
450:.
446:.
438:()
420:.
410:.
402:.
390:41
388:.
384:.
208:AB
203:.
177:,
149:,
125:,
66:,
55:)
1202:.
1176:.
1150:)
1136:.
1114::
1082:.
1056:.
1037:.
1012:.
986:.
967:.
943:.
915:.
868:.
849:.
822:.
798::
777:.
753::
731:.
707::
685:.
663:.
639::
608:.
576::
545:.
521::
490:.
458::
428:.
396::
373:.
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
